Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosoma mansoni | 29 | 2023 | 29 | 6.840 |
Why?
|
| Schistosomicides | 7 | 2023 | 7 | 2.330 |
Why?
|
| NADH, NADPH Oxidoreductases | 10 | 2023 | 10 | 2.310 |
Why?
|
| Multienzyme Complexes | 9 | 2020 | 21 | 2.250 |
Why?
|
| Helminth Proteins | 10 | 2015 | 12 | 1.970 |
Why?
|
| Schistosomiasis | 5 | 2023 | 5 | 1.460 |
Why?
|
| Animals | 37 | 2023 | 3270 | 1.400 |
Why?
|
| Schistosomiasis mansoni | 6 | 2015 | 6 | 1.310 |
Why?
|
| Gene Expression Profiling | 8 | 2019 | 108 | 1.310 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 104 | 1.190 |
Why?
|
| Aminoacyltransferases | 3 | 2013 | 3 | 1.150 |
Why?
|
| Oxidation-Reduction | 10 | 2023 | 56 | 0.900 |
Why?
|
| Molecular Sequence Data | 13 | 2013 | 176 | 0.730 |
Why?
|
| Drug Design | 4 | 2012 | 20 | 0.690 |
Why?
|
| Peroxidases | 4 | 2006 | 6 | 0.670 |
Why?
|
| Mice | 13 | 2023 | 1238 | 0.640 |
Why?
|
| Amino Acid Sequence | 11 | 2013 | 142 | 0.630 |
Why?
|
| Recombinant Proteins | 10 | 2013 | 161 | 0.620 |
Why?
|
| DNA, Helminth | 4 | 2013 | 4 | 0.550 |
Why?
|
| Anthelmintics | 3 | 2015 | 5 | 0.530 |
Why?
|
| Antigens, Helminth | 4 | 2007 | 4 | 0.520 |
Why?
|
| Phytochelatins | 2 | 2013 | 2 | 0.510 |
Why?
|
| Thioredoxin-Disulfide Reductase | 5 | 2023 | 5 | 0.500 |
Why?
|
| Albumins | 2 | 2006 | 18 | 0.490 |
Why?
|
| Oxidative Stress | 4 | 2014 | 83 | 0.490 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 2 | 0.480 |
Why?
|
| Parasitology | 2 | 2011 | 2 | 0.430 |
Why?
|
| Gene Expression | 3 | 2013 | 178 | 0.430 |
Why?
|
| Schistosoma | 2 | 2023 | 2 | 0.420 |
Why?
|
| Geranyltranstransferase | 1 | 2013 | 1 | 0.410 |
Why?
|
| Ancylostoma | 1 | 2013 | 1 | 0.410 |
Why?
|
| Diphosphonates | 1 | 2013 | 16 | 0.400 |
Why?
|
| Ovum | 2 | 2015 | 2 | 0.390 |
Why?
|
| Cestode Infections | 1 | 2012 | 1 | 0.390 |
Why?
|
| Platyhelminths | 1 | 2012 | 1 | 0.390 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 94 | 0.380 |
Why?
|
| Cloning, Molecular | 7 | 2011 | 26 | 0.380 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2013 | 32 | 0.350 |
Why?
|
| Biocatalysis | 1 | 2011 | 1 | 0.350 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 52 | 0.350 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 49 | 0.340 |
Why?
|
| Disulfides | 3 | 2023 | 10 | 0.340 |
Why?
|
| Life Cycle Stages | 3 | 2011 | 4 | 0.330 |
Why?
|
| B-Lymphocytes | 5 | 2022 | 50 | 0.330 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 4 | 0.320 |
Why?
|
| Glutathione | 4 | 2023 | 19 | 0.300 |
Why?
|
| Female | 14 | 2015 | 12958 | 0.300 |
Why?
|
| Peroxiredoxins | 5 | 2012 | 6 | 0.300 |
Why?
|
| Thioredoxins | 3 | 2023 | 5 | 0.290 |
Why?
|
| Male | 12 | 2015 | 12460 | 0.280 |
Why?
|
| Oxadiazoles | 1 | 2008 | 5 | 0.280 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 5 | 0.280 |
Why?
|
| Glutathione Reductase | 3 | 2023 | 4 | 0.280 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2020 | 4 | 0.260 |
Why?
|
| Proteome | 1 | 2007 | 23 | 0.260 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2006 | 2 | 0.250 |
Why?
|
| Sequence Alignment | 4 | 2009 | 18 | 0.240 |
Why?
|
| Models, Molecular | 3 | 2012 | 74 | 0.240 |
Why?
|
| Auranofin | 3 | 2015 | 3 | 0.230 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 76 | 0.220 |
Why?
|
| Kinetics | 3 | 2013 | 174 | 0.220 |
Why?
|
| NADP | 2 | 2023 | 6 | 0.210 |
Why?
|
| Open Reading Frames | 2 | 2015 | 9 | 0.210 |
Why?
|
| Drug Resistance | 2 | 2015 | 45 | 0.210 |
Why?
|
| Escherichia coli | 3 | 2013 | 43 | 0.200 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 8 | 0.200 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 1 | 0.200 |
Why?
|
| Adenylosuccinate Lyase | 1 | 2002 | 1 | 0.190 |
Why?
|
| Macrophages | 2 | 2022 | 78 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 363 | 0.190 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 30 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2002 | 9 | 0.190 |
Why?
|
| Humans | 13 | 2019 | 22932 | 0.190 |
Why?
|
| Candida albicans | 1 | 2022 | 2 | 0.180 |
Why?
|
| Antigens, Viral | 1 | 2022 | 9 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 12 | 0.180 |
Why?
|
| Mannans | 1 | 2022 | 5 | 0.180 |
Why?
|
| Egg Proteins | 1 | 2001 | 1 | 0.170 |
Why?
|
| Praziquantel | 2 | 2023 | 3 | 0.170 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 195 | 0.170 |
Why?
|
| Host-Parasite Interactions | 2 | 2012 | 2 | 0.160 |
Why?
|
| Expressed Sequence Tags | 3 | 2007 | 5 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2020 | 10 | 0.160 |
Why?
|
| Hydrogen Peroxide | 3 | 2006 | 39 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 55 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 102 | 0.150 |
Why?
|
| Solubility | 2 | 2022 | 18 | 0.150 |
Why?
|
| Phylogeny | 2 | 2011 | 40 | 0.150 |
Why?
|
| Biomphalaria | 2 | 2009 | 2 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 45 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 131 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 59 | 0.140 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2011 | 17 | 0.140 |
Why?
|
| Selenocysteine | 2 | 2011 | 2 | 0.130 |
Why?
|
| RNA, Messenger | 2 | 2011 | 283 | 0.130 |
Why?
|
| Base Sequence | 3 | 2006 | 99 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 22 | 0.120 |
Why?
|
| Onchocerciasis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Microfilariae | 1 | 2015 | 2 | 0.110 |
Why?
|
| Elephantiasis, Filarial | 1 | 2015 | 2 | 0.110 |
Why?
|
| Loiasis | 1 | 2015 | 2 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 226 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2007 | 24 | 0.110 |
Why?
|
| Gene Library | 2 | 2007 | 7 | 0.110 |
Why?
|
| S-Nitrosothiols | 1 | 2014 | 1 | 0.110 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cysteine | 1 | 2014 | 5 | 0.110 |
Why?
|
| Epitopes | 2 | 2022 | 39 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2013 | 20 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 58 | 0.100 |
Why?
|
| Introns | 2 | 2003 | 13 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Xenobiotics | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hydrolases | 1 | 2013 | 2 | 0.100 |
Why?
|
| Zygote | 1 | 2012 | 2 | 0.100 |
Why?
|
| Computational Biology | 1 | 2012 | 12 | 0.100 |
Why?
|
| Nitric Oxide Donors | 2 | 2014 | 6 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 8 | 0.100 |
Why?
|
| Metals | 1 | 2013 | 96 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2012 | 63 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2002 | 20 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2002 | 16 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2012 | 42 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2003 | 132 | 0.090 |
Why?
|
| Precipitin Tests | 2 | 2002 | 9 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 17 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 11 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 16 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 337 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 15 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 95 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 80 | 0.080 |
Why?
|
| Methionine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 31 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2005 | 22 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 15 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 11 | 0.070 |
Why?
|
| Naphthoquinones | 1 | 2007 | 3 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 24 | 0.070 |
Why?
|
| Disease Vectors | 1 | 2007 | 1 | 0.070 |
Why?
|
| RNA, Helminth | 1 | 2007 | 1 | 0.070 |
Why?
|
| Sex Differentiation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 4 | 0.070 |
Why?
|
| RNA Interference | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2007 | 38 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2019 | 7 | 0.060 |
Why?
|
| Markov Chains | 1 | 2006 | 30 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 140 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 4 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 6 | 0.060 |
Why?
|
| Parasite Egg Count | 2 | 2003 | 2 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 387 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 56 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 2 | 2002 | 3 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 1 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2005 | 3 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2002 | 36 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2005 | 16 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 33 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2005 | 72 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2007 | 387 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 24 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 15 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 19 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2004 | 12 | 0.050 |
Why?
|
| Electrons | 1 | 2004 | 16 | 0.050 |
Why?
|
| Protein Binding | 1 | 2004 | 112 | 0.050 |
Why?
|
| Genes, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immune Sera | 1 | 2003 | 4 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 4 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 4 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 9 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 12 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 313 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 115 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosoma haematobium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosomiasis haematobia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 13 | 0.050 |
Why?
|
| Retroelements | 1 | 2002 | 1 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 1 | 0.050 |
Why?
|
| Exons | 1 | 2002 | 28 | 0.050 |
Why?
|
| Peroxiredoxin III | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 3 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 67 | 0.050 |
Why?
|
| Glutaredoxins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 302 | 0.050 |
Why?
|
| Aluminum Hydroxide | 1 | 2022 | 1 | 0.050 |
Why?
|
| Transcription Factor RelB | 1 | 2022 | 1 | 0.050 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2022 | 1 | 0.050 |
Why?
|
| Purines | 1 | 2002 | 41 | 0.050 |
Why?
|
| Immunization | 1 | 2022 | 12 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 7 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 9 | 0.050 |
Why?
|
| beta-Glucans | 1 | 2022 | 5 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2022 | 20 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2022 | 17 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 29 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 34 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 15 | 0.050 |
Why?
|
| Proteins | 1 | 2002 | 51 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2002 | 85 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2022 | 45 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 94 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2022 | 72 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 137 | 0.040 |
Why?
|
| Paranasal Sinuses | 1 | 2022 | 61 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 90 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1261 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 2 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 227 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 3 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2019 | 12 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 31 | 0.040 |
Why?
|
| Ischemia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 19 | 0.040 |
Why?
|
| Cell Count | 1 | 2019 | 72 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2019 | 54 | 0.040 |
Why?
|
| Pneumonia | 1 | 2019 | 61 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 125 | 0.040 |
Why?
|
| Biomarkers | 1 | 2019 | 474 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2015 | 1 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 1 | 0.030 |
Why?
|
| Diethylcarbamazine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Filaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ivermectin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Loa | 1 | 2015 | 1 | 0.030 |
Why?
|
| Brugia malayi | 1 | 2015 | 1 | 0.030 |
Why?
|
| Onchocerca volvulus | 1 | 2015 | 1 | 0.030 |
Why?
|
| Albendazole | 1 | 2015 | 2 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 4 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 110 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 242 | 0.030 |
Why?
|
| Nitrosation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 33 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 70 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 592 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 243 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 8 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 273 | 0.020 |
Why?
|
| Animal Structures | 1 | 2011 | 1 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 6931 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 47 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 82 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 3 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 7 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 6 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 24 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 1882 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 7915 | 0.010 |
Why?
|